Nicholas Saraceno, Senior Editor

A study explores how supply and demand impact the value of medication.

Matt Wolf, president of biopharma services, Cencora, discusses the importance of partnership in helping to combat prescription drug abandonment and non-adherence.

Pharma Commerce editor takes a look back at 2023's impressionable editorial content.

Studies explore how both the UK and EU are handling these ongoing supply chain challenges.

Investigation notes a need for greater transparency in 340B program revenue and strengthened enforcement authority for the Health Resources and Services Administration.

The CDMO’s GMP plant will dedicate 2,500 square feet to the storage of finished products.

IQVIA report explores why these shortages are increasing, and how they can be mitigated.

Findings suggest that participants nationwide who were offered and accessed their online medical record has more than doubled in the past eight years, but racial and ethnic disparities continue.

Stem Cell Reports takes a look at DTC online advertising claims that these are ‘immune boosters.’

JMA Journal report describes how businesses in this Asian-Pacific nation are employing various strategies to reduce GHG emissions.

Session explains how to use this information to help bolster market intelligence, market access, and affordability strategies.

Conference presentation explores groundbreaking topics impacting the pharma industry.

Session explores how on-market products have done, and what to expect from new biosimilars.

Bill Roth provides insight as to how where chief commercial officers and access leaders can plan for a profitable product lifecycle.

Study describes how biotech startups can avoid competing with large pharma companies for financing.

Determination will affect future vaccine cost and accessibility, including in developing countries.

Raphael Chin Fo Sieeuw offers his insight on how to address the sector’s most prominent issues, including how to limit the industry’s carbon footprint.

The panel digs deeper into the challenges that women in the life sciences sector face.

Conference hosts roundtable chats, with topics ranging from data-driven decision making to cold chain logistics.

LogiPharma session reminds attendees of what to review, as far as DSCSA compliance is concerned.

How the links of the supply chain are fighting to preserve quality service, even against factors that may be out of their hands.

A reflection on my time with Pharma Commerce thus far, and a plan of action for moving the brand forward.

Pharma Commerce converges on Nation's Capital for HDA Traceability Seminar.

Jason Cook uncovers ways in which pharma companies can plan for weather-related challenges that may arise.

Stakeholders uncover the obstacles surrounding the industry onboarding process.

Attendees meet to discuss operational issues related to traceability implementation.

Session offers information on industry readiness, plus an overview of a phase implementation recommendation.

Event’s first session aims to analyze the legislation’s implementation, as FDA enforcement is delayed until November 2024.

In this PC Podcast episode, Susanne Katus discusses the increasing number of regulations impacting both pharma and biotech companies.

As Pharma Commerce continues to increase its conference exposure, it all could not have been possible without the help of colleagues.